The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Thyrogen and Biosimilar Market Research Report 2024

Global Thyrogen and Biosimilar Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1739069

No of Pages : 66

Ask Your Query

Synopsis
THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a genetically modified Chinese hamster ovary cell line.

Global Thyrogen and Biosimilar market is projected to reach US$ 682.6 million in 2029, increasing from US$ 257 million in 2022, with the CAGR of 15.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thyrogen and Biosimilar market research.

Key manufacturers engaged in the Thyrogen and Biosimilar industry include Sanofi and Sato Pharmaceutical etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Thyrogen and Biosimilar were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Thyrogen and Biosimilar market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Thyrogen and Biosimilar market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Sanofi
  • Sato Pharmaceutical

Segment by Type

  • Brand
  • Biosimilar

Segment by Application

  • Hospital
  • Pharmacy
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Thyrogen and Biosimilar report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Thyrogen and Biosimilar Market Overview
1.1 Product Overview and Scope of Thyrogen and Biosimilar
1.2 Thyrogen and Biosimilar Segment by Type
1.2.1 Global Thyrogen and Biosimilar Market Value Comparison by Type (2023-2029)
1.2.2 Brand
1.2.3 Biosimilar
1.3 Thyrogen and Biosimilar Segment by Application
1.3.1 Global Thyrogen and Biosimilar Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Thyrogen and Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Thyrogen and Biosimilar Revenue 2018-2029
1.4.2 Global Thyrogen and Biosimilar Sales 2018-2029
1.4.3 Global Thyrogen and Biosimilar Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Thyrogen and Biosimilar Market Competition by Manufacturers
2.1 Global Thyrogen and Biosimilar Sales Market Share by Manufacturers (2018-2023)
2.2 Global Thyrogen and Biosimilar Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Thyrogen and Biosimilar Average Price by Manufacturers (2018-2023)
2.4 Global Thyrogen and Biosimilar Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Thyrogen and Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Thyrogen and Biosimilar, Product Type & Application
2.7 Thyrogen and Biosimilar Market Competitive Situation and Trends
2.7.1 Thyrogen and Biosimilar Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Thyrogen and Biosimilar Players Market Share by Revenue
2.7.3 Global Thyrogen and Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Thyrogen and Biosimilar Retrospective Market Scenario by Region
3.1 Global Thyrogen and Biosimilar Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Thyrogen and Biosimilar Global Thyrogen and Biosimilar Sales by Region: 2018-2029
3.2.1 Global Thyrogen and Biosimilar Sales by Region: 2018-2023
3.2.2 Global Thyrogen and Biosimilar Sales by Region: 2024-2029
3.3 Global Thyrogen and Biosimilar Global Thyrogen and Biosimilar Revenue by Region: 2018-2029
3.3.1 Global Thyrogen and Biosimilar Revenue by Region: 2018-2023
3.3.2 Global Thyrogen and Biosimilar Revenue by Region: 2024-2029
3.4 North America Thyrogen and Biosimilar Market Facts & Figures by Country
3.4.1 North America Thyrogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Thyrogen and Biosimilar Sales by Country (2018-2029)
3.4.3 North America Thyrogen and Biosimilar Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Thyrogen and Biosimilar Market Facts & Figures by Country
3.5.1 Europe Thyrogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Thyrogen and Biosimilar Sales by Country (2018-2029)
3.5.3 Europe Thyrogen and Biosimilar Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Thyrogen and Biosimilar Market Facts & Figures by Country
3.6.1 Asia Pacific Thyrogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Thyrogen and Biosimilar Sales by Country (2018-2029)
3.6.3 Asia Pacific Thyrogen and Biosimilar Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Thyrogen and Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Thyrogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Thyrogen and Biosimilar Sales by Country (2018-2029)
3.7.3 Latin America Thyrogen and Biosimilar Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Thyrogen and Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Thyrogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Thyrogen and Biosimilar Sales by Country (2018-2029)
3.8.3 Middle East and Africa Thyrogen and Biosimilar Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Thyrogen and Biosimilar Sales by Type (2018-2029)
4.1.1 Global Thyrogen and Biosimilar Sales by Type (2018-2023)
4.1.2 Global Thyrogen and Biosimilar Sales by Type (2024-2029)
4.1.3 Global Thyrogen and Biosimilar Sales Market Share by Type (2018-2029)
4.2 Global Thyrogen and Biosimilar Revenue by Type (2018-2029)
4.2.1 Global Thyrogen and Biosimilar Revenue by Type (2018-2023)
4.2.2 Global Thyrogen and Biosimilar Revenue by Type (2024-2029)
4.2.3 Global Thyrogen and Biosimilar Revenue Market Share by Type (2018-2029)
4.3 Global Thyrogen and Biosimilar Price by Type (2018-2029)
5 Segment by Application
5.1 Global Thyrogen and Biosimilar Sales by Application (2018-2029)
5.1.1 Global Thyrogen and Biosimilar Sales by Application (2018-2023)
5.1.2 Global Thyrogen and Biosimilar Sales by Application (2024-2029)
5.1.3 Global Thyrogen and Biosimilar Sales Market Share by Application (2018-2029)
5.2 Global Thyrogen and Biosimilar Revenue by Application (2018-2029)
5.2.1 Global Thyrogen and Biosimilar Revenue by Application (2018-2023)
5.2.2 Global Thyrogen and Biosimilar Revenue by Application (2024-2029)
5.2.3 Global Thyrogen and Biosimilar Revenue Market Share by Application (2018-2029)
5.3 Global Thyrogen and Biosimilar Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Thyrogen and Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Thyrogen and Biosimilar Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Sato Pharmaceutical
6.2.1 Sato Pharmaceutical Corporation Information
6.2.2 Sato Pharmaceutical Description and Business Overview
6.2.3 Sato Pharmaceutical Thyrogen and Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sato Pharmaceutical Thyrogen and Biosimilar Product Portfolio
6.2.5 Sato Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Thyrogen and Biosimilar Industry Chain Analysis
7.2 Thyrogen and Biosimilar Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Thyrogen and Biosimilar Production Mode & Process
7.4 Thyrogen and Biosimilar Sales and Marketing
7.4.1 Thyrogen and Biosimilar Sales Channels
7.4.2 Thyrogen and Biosimilar Distributors
7.5 Thyrogen and Biosimilar Customers
8 Thyrogen and Biosimilar Market Dynamics
8.1 Thyrogen and Biosimilar Industry Trends
8.2 Thyrogen and Biosimilar Market Drivers
8.3 Thyrogen and Biosimilar Market Challenges
8.4 Thyrogen and Biosimilar Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock